Quick-Med Technologies, Inc.announced that it has received clearance from the U.S. Food and Drug Administration to market and distribute its patented NIMBUS® barrier gauze wound care dressings. This represents the first FDA clearance for NIMBUS ? an innovative technology that is so unique and cutting edge that it was put through FDA?s De Novo process, [...]
Read...Related Headlines
- Nationwide v. Leonard: Fifth Circuit upholds anti-concurrent cause provision as unambiguousposted 247 weeks ago on Insurance Coverage Blog
- More misunderstandings of anti-concurrent cause languageposted 245 weeks ago on Insurance Coverage Blog
- Landry v. Citizens Property: Louisiana Court of Appeals sows confusion, messes up causation analysis in Hurricane Rita cposted 247 weeks ago on Insurance Coverage Blog
- Fifth Circuit hears arguments in Leonard v. Nationwide Katrina appealposted 250 weeks ago on Insurance Coverage Blog
- A last word this week on In Re Katrina Canal Breaches Litigationposted 251 weeks ago on Insurance Coverage Blog
-
Colorado Court of Appeals: anti-concurrent cause provision bars coverage where covered snow combined with uncovereposted 198 weeks ago on Insurance Coverage Blog
- Commentary on Fifth Circuit's decision in Tuepker v. State Farmposted 237 weeks ago on Insurance Coverage Blog
- Final version of Appleman's anti-concurrent cause/Katrina litigation articleposted 244 weeks ago on Insurance Coverage Blog
- More on Northrop Grumman v. Factory Mutualposted 247 weeks ago on Insurance Coverage Blog
- Anti-concurrent cause language articleposted 248 weeks ago on Insurance Coverage Blog